The global intermittent catheters market is on a trajectory of steady growth, as indicated by a recent study conducted by the publisher. In 2023, the market was valued at US$1.8 billion, and it is anticipated to maintain a Compound Annual Growth Rate (CAGR) of 4.8% over the next decade, reaching an estimated valuation of approximately US$2.5 billion by the end of 2031.
The global geriatric population, aged 65 and older, is growing significantly. The United Nations predicts that by 2050, this demographic will double to 1.5 billion people. As older individuals require continuous care monitoring, healthcare professionals often use intermittent catheters to ease their care burdens, even in post-surgical situations.
Additionally, the rising incidence of bladder control problems and urinary-related issues in countries like the U.S., Australia, and the U.K. is driving market growth. For example, in Australia, urinary incontinence affects 1 in 3 women, 1 in 10 men, and 1 in 5 children, according to the Continence Foundation of Australia.
To address the growing demand for safer and more efficient catheters, companies are investing in Research and Development (R&D) initiatives to produce biocompatible urinary catheters. Materials like silicone, known for their resistance to chemicals and temperature insensitivity, are becoming more prevalent in catheter production. Silicone catheters reduce the risk of complications such as trigonitis, meatitis, and urethritis compared to traditional latex catheters. Silicone catheters also have the advantage of longer usability, reducing the need for frequent replacements.
The availability of disposable incontinence products, such as adult diapers and pull-on absorbent trousers, serves as a substitute for external catheters, further affecting market growth. Governments in countries like the U.S., U.K., and Australia offer reimbursement programs for disposable incontinence products, potentially hampering the intermittent catheters market during the forecast period.
This product will be delivered within 1-3 business days.
Meeting Critical Medical Needs
Intermittent catheters serve as a crucial medical device for patients requiring effective urine drainage or collection. This method is especially essential for individuals with spinal cord injuries and neurogenic bladder problems, allowing them to efficiently manage their bladder functions.Driving Factors for Market Growth
The increasing prevalence of urinary incontinence is expected to drive the demand for intermittent catheters. Urinary incontinence, a condition that affects bladder control and leads to involuntary urine leakage, is becoming more prevalent. It affects a broad spectrum of the population, including the elderly, who commonly use intermittent catheters for various medical conditions such as urine retention, incontinence, pressure ulcers, and cancer.The global geriatric population, aged 65 and older, is growing significantly. The United Nations predicts that by 2050, this demographic will double to 1.5 billion people. As older individuals require continuous care monitoring, healthcare professionals often use intermittent catheters to ease their care burdens, even in post-surgical situations.
Additionally, the rising incidence of bladder control problems and urinary-related issues in countries like the U.S., Australia, and the U.K. is driving market growth. For example, in Australia, urinary incontinence affects 1 in 3 women, 1 in 10 men, and 1 in 5 children, according to the Continence Foundation of Australia.
Increasing Awareness and Benefits of Catheterization
Growing awareness among physicians and patients about the benefits of catheterization is expected to further boost demand for intermittent catheters in the coming years. Medical professionals and patients alike are recognizing the advantages of this medical solution, contributing to market growth.Opportunities for Manufacturers
Manufacturers of intermittent catheters have a substantial opportunity to address the unmet needs of a large patient pool in developing regions. In areas like Asia Pacific and Latin America, there is significant room for growth, as the penetration of urinary catheter use remains low compared to industrialized regions. Rising healthcare spending, increased awareness among patients and physicians, and technological advancements are expected to create significant growth prospects in developing nations such as China, Russia, and India.To address the growing demand for safer and more efficient catheters, companies are investing in Research and Development (R&D) initiatives to produce biocompatible urinary catheters. Materials like silicone, known for their resistance to chemicals and temperature insensitivity, are becoming more prevalent in catheter production. Silicone catheters reduce the risk of complications such as trigonitis, meatitis, and urethritis compared to traditional latex catheters. Silicone catheters also have the advantage of longer usability, reducing the need for frequent replacements.
Challenges Faced by the Market
Despite its promising growth, the intermittent catheters market faces challenges related to the increasing incidence of urinary tract infections associated with catheter use. Catheter-associated urinary tract infections (CAUTIs) pose a significant challenge for healthcare professionals and institutions. For instance, over 80% of catheter CAUTIs are attributed to catheterizations using Foley or indwelling urinary catheters, according to the Centers for Disease Control and Prevention (CDC) of the U.S.The availability of disposable incontinence products, such as adult diapers and pull-on absorbent trousers, serves as a substitute for external catheters, further affecting market growth. Governments in countries like the U.S., U.K., and Australia offer reimbursement programs for disposable incontinence products, potentially hampering the intermittent catheters market during the forecast period.
Country-wise Insights
U.S.: A Growing Demand for Medical Devices
Intermittent catheter manufacturers are increasingly focusing on the U.S. market, driven by several key factors. The United States dominated the North American intermittent catheter market in 2023. The rising demand for these medical devices in the U.S. can be attributed to the growing number of medical device and surgical instrument companies in the country. Moreover, improvements in quality control systems within the industrial sector have contributed to the surge in demand. Additionally, the prevalence of urinary incontinence in the U.S. is a significant driver for intermittent catheter demand, with millions of adult Americans affected, particularly women.Germany: Opportunities in New Technologies
Germany has witnessed an increasing demand for intermittent catheters, holding a significant share of the European market in 2023. This demand is primarily linked to the country's growing geriatric population. As per World Bank data, a substantial percentage of the German population was 65 years and older in 2020, leading to a higher need for intermittent catheters. Furthermore, ongoing research studies aimed at providing safer alternatives for catheterization are also contributing to the attractiveness of the German market for intermittent catheters.Japan: A Hub for Healthcare
Japan is considered a lucrative market for intermittent catheter suppliers, with a notable market share in East Asia in 2023. The presence of numerous hospitals and a high availability of hospital beds per 1,000 people drive the demand for intermittent catheters. Japan's healthcare sector is well-established, making it a prominent market for suppliers.Competitive Analysis
Companies manufacturing intermittent catheters are actively seeking ways to enhance their market positions through partnerships, acquisitions, collaborations, and approvals with both existing and emerging market players.Key Companies Profiled
- Boston Scientific Corporation
- Medtronic plc.
- Hollister Incorporate
- B. Braun Melsungen AG
- Coloplast A/S
- Becton, Dickinson, and Company
- Teleflex Incorporation
- Cook Medical
- ASID BONZ GmbH
- Hunter Urology Ltd.
- McKesson Corp.
- Medline Industries LP
- Pennine Healthcare
- Romsons
- Convatec
- FlexicareScienta Omicron (Scienta Scientific)
- PREVAC SP. Z O.O.
- Nova Ltd.
- SPECS GmbH
Segments Covered in Intermittent Catheters Industry Survey
By Product:
- Coated Intermittent Catheters
- Uncoated Intermittent Catheters
By Application:
- Urinary Incontinence
- Urinary Retention
- Prostate Gland Surgery
- Spinal Cord Injury
- Other
By End User:
- Hospitals
- Surgical Centers
- Specialty Clinics
- Academic & Research Institutions
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Production Output and Trade Statistics, 2018 - 2023
4. Price Analysis, 2018 - 2023
5. Global Intermittent Catheters Market Outlook, 2018 - 2031
6. North America Intermittent Catheters Market Outlook, 2018 - 2031
7. Europe Intermittent Catheters Market Outlook, 2018 - 2031
8. Asia Pacific Intermittent Catheters Market Outlook, 2018 - 2031
9. Latin America Intermittent Catheters Market Outlook, 2018 - 2031
10. Middle East & Africa Intermittent Catheters Market Outlook, 2018 - 2031
11. Competitive Landscape
12. Appendix
Companies Mentioned
- Boston Scientific Corporation
- Medtronic plc.
- Hollister Incorporate
- B. Braun Melsungen AG
- Coloplast A/S
- Becton, Dickinson, and Company
- Teleflex Incorporation
- Cook Medical
- ASID BONZ GmbH
- Hunter Urology Ltd.
- McKesson Corp.
- Medline Industries LP
- Pennine Healthcare
- Romsons
- Convatec
Methodology
LOADING...